Plunkett Research Online: Wilex AG

WILEX AG (WLXMF) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

WILEX is a biopharmaceutical company that develops drugs based on antibodies and small molecules with a low side effect profile and targeted treatment of different types of cancer, as well as diagnostic agents for specific detection of tumours. WILEX’s aim is to help oncologists administer targeted .....


WILEX AG

Ticker: WLXMF
Exchange: GREY
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 49 894131380
Fax: 49 8941313899
Address: Wilex AG
München, 81675 Germany

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

WILEX is a biopharmaceutical company that develops drugs based on antibodies and small molecules with a low side effect profile and targeted treatment of different types of cancer, as well as diagnostic agents for specific detection of tumours. WILEX’s aim is to help oncologists administer targeted .....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture